| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| American Medical Laboratories, Incorporated |
| 14225 Newbrook Drive, Chantilly, VA 20153 * (703) 802-6900 |
| Business Description | The company is a leading provider of esoteric testing services to a wide range of healthcare professionals nationwide and are the largest provider of esoteric and routine laboratory testing services in our core geographic markets of metropolitan Washington, D.C. and Nevada. |
|
Filing Information Not yet | |||
| To Trade As | AMJ (NYSE) | Industry | Service (SIC 8071) |
| Type of Stock Offered | Common Shares | Filing Date | 11/19/2001 |
| Domestic Shares Filed | 0 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $100,000,000 |
| Company Shares | 0 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| CS First Boston | Lead Manager | (212) 325-2000 |
| Banc of America Securities LLC | Co-manager | (415) 627-2100 |
| U.S. Bancorp Piper Jaffray | Co-manager | (612) 342-6220 |
| Wachovia Securities, Inc. | Co-manager |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1999 | 12/31/2000 | 9/30/2000 | 9/30/2001 | |||
| Revenues | - | - | - | 143.436 | 260.824 | 196.329 | 221.500 |
| Income from Oper. | - | - | - | 8.991 | 17.541 | 16.119 | 17.289 |
| Net Income | - | - | - | 0.774 | -1.809 | 0.790 | 0.896 |
| E.P.S | - | - | - | 0.060 | -0.090 | 0.040 | 0.040 |
| Revenue Growth (%) | - | - | - | 81.840 | 12.82 | ||
| Net Income Growth (%) | - | - | - | - | 13.42 | ||
| Oper. Profit Margin (%) | - | - | - | 6.27 | 6.73 | 7.81 | 8.21 |
| Net Profit Margin (%) | - | - | - | 0.54 | - | 0.40 | 0.40 |
| Cash Flow - Oper. | 12.82 | - | - | ||||
| Cash Flow - Inv. | -19.01 | - | - | ||||
| Cash Flow - Fin. | 6.14 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 9/30/2001 | Financial Ratios | ||||
| Total Assets | 203.91 | Current Assets | - | Current Ratio | - |
| Total Liab. | 193.56 | Current Liab. | - | Debt Ratio | 94.93% |
| Total Equity | 10.35 | Working Cap. | - | Debt to Equity Ratio | 18.71 |
| Cash | 3.52 | Return on Assets | 0.44% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay indebtedness and to repurchase redeemable cumulative preferred stock. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Kirkland & Ellis |
| Bank's Law Firm | Latham & Watkins |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | KPMG LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Golder, Thoma, Cressey, Rauner Fund V, L.P. | 65.30 | |
| Note: represents ownership of 5% or more prior to the offering. | ||